FMC Corporation reported a challenging third quarter with net sales declining 49% year-over-year, largely due to inventory adjustments in India and price pressures in Latin America. Adjusted EBITDA improved 17%, reflecting disciplined cost management despite external pressures.

• Third quarter GAAP net sales reached $542 million, significantly impacted by India's inventory actions and Brazil's credit constraints.
• Excluding India, revenue fell 4% year-over-year, driven by a 6% price decline and an 8% sales lag in Latin America.
• Adjusted EBITDA was $236 million, up 17% year-over-year, benefiting from strong cost control and increased demand for new active ingredients.
• Adjusted EPS improved 30%, reaching $0.89, supported by the enhanced EBITDA performance.
• Anticipated fourth quarter sales (excluding India) are projected between $1.12 billion and $1.22 billion, with continued pricing pressures expected.